851091-96-8 (VX765 抑制剂,VX765)

VX765 抑制剂;

VX765;(S)-1-((S)-2-(4-amino-3-chlorobenzamido)-3,3-dimethylbutanoyl)-N-((2R,3S)-2-ethoxy-5-oxotetrahydrofuran-3-yl)pyrrolidine-2-carboxamide;Belnacasan [USAN:INN];DTXCID901475833;L-Prolinamide, N-(4-amino-3-chlorobenzoyl)-3-methyl-l-valyl-N-((2R,3S)-2-ethoxytetrahydro-5-oxo-3-furanyl)-;N-(4-Amino-3-chlorobenzoyl)-3-methyl-L-valyl-N-[(2R,3S)-2-ethoxytetrahydro-5-oxo-3-furanyl]-L-prolinamide;MFCD11100350;s2228;NCGC00183682-10;(s)-1-((s)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2r,3s)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide;BELNACASAN [INN];NCGC00183682-13;Q27075000;VX 765;V0176;1-((2S)-2-((4-AMINO-3-CHLOROBENZOYL)AMINO)-3,3-DIMETHYLBUTANOYL)-N-((2R,3S)-2-ETHOXY-5-OXO-TETRAHYDROFURAN-3-YL)-L-PROLINAMIDE;1-(2-((1-(4-Amino-3-chlorophenyl)methanoyl)amino)-3,3-dimethylbutanoyl)pyrrolidine-2-carboxylic acid;GTPL9035;AKOS024464751;BELNACASAN [WHO-DD];Belnacasan(VX-765);NCGC00183682-09;1-((2S)-2-(4-AMINO-3-CHLOROBENZAMIDO)-3,3-DIMETHYLBUTANOYL)-N-((2R,3S)-2-ETHOXY-5-OXOOXOLAN-3-YL)-L-PROLINAMIDE;BCP0726000319;D10416;851091-96-8;Belnacasan (USAN/INN);AS-35159;00OLE78529;Belnacasan [USAN];1-((2S)-2-((4-Amino-3-chlorobenzoyl)amino)-3,3-dimethylbutanoyl)-N-((2R,3S)-2- ethoxy-5-oxo-tetrahydrofuran-3-yl)-l-prolinamide;DTXSID901017651;(2S)-1-[(2S)-2-[(4-amino-3-chlorophenyl)formamido]-3,3-dimethylbutanoyl]-N-[(2R,3S)-2-ethoxy-5-oxooxolan-3-yl]pyrrolidine-2-carboxamide;BELNACASAN;CCG-269769;belcanasan;Belnacasan (USAN);(2S)-1-((2S)-2-((4-amino-3-chlorobenzoyl)amino)-3,3-dimethylbutanoyl)-N-((2R,3S)-2-ethoxy-5-oxooxolan-3-yl)pyrrolidine-2-carboxamide;Belnacasan (VX765);CHEBI:188567;Belnacasan (VX-765);HMS3884B11;Belnacasan (VX-765)?;CHEMBL2107819;(2S)-1-[(2S)-2-[(4-amino-3-chlorobenzoyl)amino]-3,3-dimethylbutanoyl]-N-[(2R,3S)-2-ethoxy-5-oxooxolan-3-yl]pyrrolidine-2-carboxamide;FV137735;VX-765;vx-765 (Belnacasan);L-Prolinamide, N-(4-amino-3-chlorobenzoyl)-3-methyl-L-valyl-N-[(2R,3S)-2-ethoxytetrahydro-5-oxo-3-furanyl]-; N-(4-Amino-3-chlorobenzoyl)-3-methyl-L-valyl-N-[(2R,3S)-2-ethoxytetrahydro-5-oxo-3-furanyl]-L-prolinamide; Belnacasan; VX 765;(S)-1-((S)-2-1((-(4-amino-3-chloro-phenyl)-methanoyl)-amino)-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide;SCHEMBL3393597;belnacasanum;273404-37-8;UNII-00OLE78529;

SJDDOCKBXFJEJB-MOKWFATOSA-N

1S/C24H33ClN4O6/c1-5-34-23-16(12-18(30)35-23)27-21(32)17-7-6-10-29(17)22(33)19(24(2,3)4)28-20(31)13-8-9-15(26)14(25)11-13/h8-9,11,16-17,19,23H,5-7,10,12,26H2,1-4H3,(H,27,32)(H,28,31)/t16-,17-,19+,23+/m0/s1

ClC1=C(C=CC(=C1)C(N[C@H](C(N1CCC[C@H]1C(N[C@H]1CC(=O)O[C@H]1OCC)=O)=O)C(C)(C)C)=O)N